The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
Sorrento Therapeutics Shares Spike Higher; Co Announces Its Lead Protein-Based COVID-19 Vaccine Candidate Elicits ‘Strong Neutralizing Immune Responses’ In Vaccinated Animals Against SARS-CoV-2 And Multiple Major Variants Of Concern
Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits Strong Neutralizing Immune Responses in Vaccinated Animals Against SARS-CoV-2 and Multiple Major Variants of
Sorrento’s Scilex Holding Says, Effective Sept. 1, ZTlido Has Been Added To Multiple Formularies
Scilex Holding Company (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE), announced that, effective September 1, 2021, ZTlido® (lidocaine topical system) 1.8% has been added to multiple
Dyadic Stock Jumps On Development Pact With Sorrento For Diagnostics & Therapies For Coronaviruses
Dyadic International Inc (NASDAQ:DYAI) and Sorrento Therapeutics Inc (NASDAQ:SRNE) have announced a binding term sheet for a License Agreement to develop and commercialize…
Benzinga Pro’s Top 5 Stocks To Watch For Wednesday, Aug. 11, 2021: XLK, ZEV, DYAI, FULC, BLNK
Today's 5 Stock Ideas:
SPDR Select Fund - Technology (XLK) - This ETF was indicated higher Wednesday morning following cooler-than-expected inflation data for the month of July. The month-over-month
Sorrento Therapeutics Granted U.S. Patent Titled ‘Method for increasing permeability of a cellular layer of epithelial cells’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6534&f=G&l=50&d=PTXT&p=131&S1=20210810&OS=20210810&RS=20210810
Sorrento Unveils Overview Of Its MultiValent mRNA COVID-19 Vaccine Development Program
Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", , Sorrento", , )))), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the
10 Health Care Stocks Showing Unusual Options Activity In Today’s Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.